These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12513906)

  • 1. The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.
    Santini SM; Di Pucchio T; Lapenta C; Parlato S; Logozzi M; Belardelli F
    J Interferon Cytokine Res; 2002 Nov; 22(11):1071-80. PubMed ID: 12513906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of type I interferon in inducing a protective immune response: perspectives for clinical applications.
    Rizza P; Moretti F; Capone I; Belardelli F
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):195-201. PubMed ID: 25466627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
    Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
    Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation.
    Soumelis V; Liu YJ
    Eur J Immunol; 2006 Sep; 36(9):2286-92. PubMed ID: 16892183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferons as regulators of the differentiation/activation of human dendritic cells: methods for the evaluation of IFN-induced effects.
    Santini SM; Lapenta C; Belardelli F
    Methods Mol Med; 2005; 116():167-81. PubMed ID: 16000861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking innate to adaptive immunity through dendritic cells.
    Steinman RM
    Novartis Found Symp; 2006; 279():101-9; discussion 109-13, 216-9. PubMed ID: 17278389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation.
    Tough DF
    Leuk Lymphoma; 2004 Feb; 45(2):257-64. PubMed ID: 15101709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The type I IFN system in rheumatoid arthritis.
    Conigliaro P; Perricone C; Benson RA; Garside P; Brewer JM; Perricone R; Valesini G
    Autoimmunity; 2010 Apr; 43(3):220-5. PubMed ID: 20166872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.
    Liu YJ
    Annu Rev Immunol; 2005; 23():275-306. PubMed ID: 15771572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferons as regulators of human antigen presenting cell functions.
    Gessani S; Conti L; Del Cornò M; Belardelli F
    Toxins (Basel); 2014 May; 6(6):1696-723. PubMed ID: 24866026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers.
    Diebold SS; Montoya M; Unger H; Alexopoulou L; Roy P; Haswell LE; Al-Shamkhani A; Flavell R; Borrow P; Reis e Sousa C
    Nature; 2003 Jul; 424(6946):324-8. PubMed ID: 12819664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
    Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
    Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bidirectional crosstalk between human dendritic cells and natural killer cells.
    Wehner R; Dietze K; Bachmann M; Schmitz M
    J Innate Immun; 2011; 3(3):258-63. PubMed ID: 21411969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF family proteins and type I interferon induction in dendritic cells.
    Tailor P; Tamura T; Ozato K
    Cell Res; 2006 Feb; 16(2):134-40. PubMed ID: 16474425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential type I interferon activation and susceptibility of dendritic cell populations to porcine arterivirus.
    Loving CL; Brockmeier SL; Sacco RE
    Immunology; 2007 Feb; 120(2):217-29. PubMed ID: 17116172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interferon regulatory factor 3 in type I interferon responses in rotavirus-infected dendritic cells and fibroblasts.
    Douagi I; McInerney GM; Hidmark AS; Miriallis V; Johansen K; Svensson L; Karlsson Hedestam GB
    J Virol; 2007 Mar; 81(6):2758-68. PubMed ID: 17215281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoid dendritic cells in immunity.
    Colonna M; Trinchieri G; Liu YJ
    Nat Immunol; 2004 Dec; 5(12):1219-26. PubMed ID: 15549123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists.
    Kreutz M; Bakdash G; Dolen Y; Sköld AE; van Hout-Kuijer MA; de Vries IJ; Figdor CG
    Eur J Immunol; 2015 Oct; 45(10):2798-809. PubMed ID: 26255864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα.
    Liu X; Zhan Z; Xu L; Ma F; Li D; Guo Z; Li N; Cao X
    J Immunol; 2010 Dec; 185(12):7244-51. PubMed ID: 21068402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.